Subaru Corporation (FUJHF)

Verve Therapeutics Revenue

In the fiscal year ending March 31, 2025, Subaru had annual revenue of 4.69T JPY, down -0.37%. Subaru had revenue of 1.15T in the quarter ending March 31, 2025, a decrease of -4.73%.

• Revenue: 4,685.76B JPY
• Revenue Growth: -0.37%
• P/S Ratio: 0.44
• Revenue / Employee: 123.75M JPY
• Employees: 37,866
• Market Cap: 13.90B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4,685.76B	-17.18B	-0.37%
Mar 31, 2024	4,702.95B	928.48B	24.60%
Mar 31, 2023	3,774.47B	1,029.95B	37.53%
Mar 31, 2022	2,744.52B	-85.69B	-3.03%
Mar 31, 2021	2,830.21B	-513.90B	-15.37%